TW201511766A - 用於增進男性性健康之方法及組合物 - Google Patents
用於增進男性性健康之方法及組合物 Download PDFInfo
- Publication number
- TW201511766A TW201511766A TW103129078A TW103129078A TW201511766A TW 201511766 A TW201511766 A TW 201511766A TW 103129078 A TW103129078 A TW 103129078A TW 103129078 A TW103129078 A TW 103129078A TW 201511766 A TW201511766 A TW 201511766A
- Authority
- TW
- Taiwan
- Prior art keywords
- extract
- vitamin
- pharmaceutical composition
- lichens
- vinpocetine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 36
- 238000000034 method Methods 0.000 title description 6
- 230000001568 sexual effect Effects 0.000 title description 5
- 230000002708 enhancing effect Effects 0.000 title description 3
- 239000000419 plant extract Substances 0.000 claims abstract description 22
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 19
- 239000011707 mineral Substances 0.000 claims abstract description 19
- 241000233866 Fungi Species 0.000 claims abstract description 17
- 150000001413 amino acids Chemical class 0.000 claims abstract description 13
- 239000003937 drug carrier Substances 0.000 claims abstract description 11
- 150000001412 amines Chemical class 0.000 claims abstract description 9
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 239000011782 vitamin Substances 0.000 claims abstract description 8
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 201000001880 Sexual dysfunction Diseases 0.000 claims abstract description 7
- 231100000872 sexual dysfunction Toxicity 0.000 claims abstract description 7
- 241000195493 Cryptophyta Species 0.000 claims abstract description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 14
- 239000000284 extract Substances 0.000 claims description 54
- 240000000759 Lepidium meyenii Species 0.000 claims description 17
- 235000000421 Lepidium meyenii Nutrition 0.000 claims description 17
- 235000012902 lepidium meyenii Nutrition 0.000 claims description 17
- 241000212948 Cnidium Species 0.000 claims description 16
- DDNCQMVWWZOMLN-IRLDBZIGSA-N Vinpocetine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C=C(C(=O)OCC)N5C2=C1 DDNCQMVWWZOMLN-IRLDBZIGSA-N 0.000 claims description 15
- 229960000744 vinpocetine Drugs 0.000 claims description 15
- 229940032991 zinc picolinate Drugs 0.000 claims description 13
- NHVUUBRKFZWXRN-UHFFFAOYSA-L zinc;pyridine-2-carboxylate Chemical compound C=1C=CC=NC=1C(=O)O[Zn]OC(=O)C1=CC=CC=N1 NHVUUBRKFZWXRN-UHFFFAOYSA-L 0.000 claims description 13
- 240000004713 Pisum sativum Species 0.000 claims description 11
- 235000001014 amino acid Nutrition 0.000 claims description 11
- 241000190633 Cordyceps Species 0.000 claims description 10
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 10
- 229930064664 L-arginine Natural products 0.000 claims description 10
- 235000014852 L-arginine Nutrition 0.000 claims description 10
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 3
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 235000011229 Prunus domestica subsp. syriaca Nutrition 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- 244000169641 Spondias dulcis Species 0.000 claims description 3
- 235000005138 Spondias dulcis Nutrition 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 108700003601 dimethylglycine Proteins 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 229910052750 molybdenum Inorganic materials 0.000 claims description 3
- 239000011733 molybdenum Substances 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 2
- 244000111261 Mucuna pruriens Species 0.000 claims description 2
- 235000006161 Mucuna pruriens Nutrition 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
- 244000296102 Selinum monnieri Species 0.000 claims description 2
- 235000019084 Selinum monnieri Nutrition 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- 229930003537 Vitamin B3 Natural products 0.000 claims description 2
- 229930003571 Vitamin B5 Natural products 0.000 claims description 2
- 229930003756 Vitamin B7 Natural products 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 229930003316 Vitamin D Natural products 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 229930003448 Vitamin K Natural products 0.000 claims description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 2
- 229960002079 calcium pantothenate Drugs 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 235000019160 vitamin B3 Nutrition 0.000 claims description 2
- 239000011708 vitamin B3 Substances 0.000 claims description 2
- 239000011675 vitamin B5 Substances 0.000 claims description 2
- 235000009492 vitamin B5 Nutrition 0.000 claims description 2
- 235000019158 vitamin B6 Nutrition 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 235000011912 vitamin B7 Nutrition 0.000 claims description 2
- 239000011735 vitamin B7 Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 235000019168 vitamin K Nutrition 0.000 claims description 2
- 239000011712 vitamin K Substances 0.000 claims description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 229940046008 vitamin d Drugs 0.000 claims description 2
- 229940046010 vitamin k Drugs 0.000 claims description 2
- 229960005069 calcium Drugs 0.000 claims 1
- 229940060038 chlorine Drugs 0.000 claims 1
- 229960003975 potassium Drugs 0.000 claims 1
- 229940083542 sodium Drugs 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 description 17
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 6
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 5
- 125000004383 glucosinolate group Chemical group 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 239000005414 inactive ingredient Substances 0.000 description 4
- 229960004502 levodopa Drugs 0.000 description 4
- 241000219193 Brassicaceae Species 0.000 description 3
- 206010057672 Male sexual dysfunction Diseases 0.000 description 3
- 230000036299 sexual function Effects 0.000 description 3
- 230000035911 sexual health Effects 0.000 description 3
- 244000061520 Angelica archangelica Species 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 244000060234 Gmelina philippensis Species 0.000 description 2
- 241000257303 Hymenoptera Species 0.000 description 2
- 235000019774 Rice Bran oil Nutrition 0.000 description 2
- 244000100205 Robinia Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000008165 rice bran oil Substances 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 229940005741 sunflower lecithin Drugs 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PGRNZHOQVAPMFX-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;2-oxopentanedioic acid Chemical compound OC(=O)CCC(=O)C(O)=O.OC(=O)[C@@H](N)CCCN=C(N)N PGRNZHOQVAPMFX-WCCKRBBISA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical class C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 235000007070 Angelica archangelica Nutrition 0.000 description 1
- 241001254604 Angelica pubescens Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 241000873224 Capparaceae Species 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 241000219172 Caricaceae Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241001060713 Drypetes Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 244000290889 Phoenix sylvestris Species 0.000 description 1
- 235000005805 Prunus cerasus Nutrition 0.000 description 1
- 240000002878 Prunus cerasus Species 0.000 description 1
- 206010038967 Retrograde ejaculation Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015421 male orgasm disease Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 230000036332 sexual response Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- -1 sunflower lecithin Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本發明係關於醫藥組合物,其包含一或多種植物提取物及/或其衍生物,一或多種維生素及/或礦物質、一或多種真菌、藻類及/或地衣,及一或多種醫藥學上可接受之載劑。該醫藥組合物可進一步包含一或多種胺基酸及/或其衍生物。該一或多種植物提取物、該一或多種維生素或礦物質、該一或多種真菌、藻類或地衣及視情況該一或多種胺基酸及/或其衍生物係以足以治療或改善患者之性功能障礙之量存在。
Description
本發明大體上係關於營養組合物,且更特定言之,係關於用於增進男性性健康或功能之方法及組合物。
男性性功能障礙之特徵為性反應或性慾之持續的、反覆的問題。許多男性在其一生中之某個時期經歷性功能障礙問題。男性性功能障礙之類型包括,僅列舉幾例,***障礙、早洩、男性高潮障礙、性慾過抑或缺乏、逆行***及異常***。因為性反應過於複雜,涉及多種因素,所以存在許多引起性功能障礙之原因,包括生理及心理原因。
除男性性功能障礙以外,亦存在很多罹患性不滿足之男性,該性不滿足並非真正地在本質上功能異常或與醫學病狀相關。此男性群體希望藉由改善或增進其性體驗之品質來達成性滿足。
因此,男性仍存在此需求:希望以安全、有效且無顯著副作用的方式治療性功能障礙或達成性滿足。
在一個實施例中,營養組合物包含以下中之一者或其組合:(1)植物提取物及/或其衍生物,(2)一或多種礦物質,及(3)一或多種地衣或真菌。在尤其較佳實施例中,營養組合物包含至少一種植物提取物
及/或其衍生物、至少一種礦物質及至少一種地衣或真菌。
在另一實施例中,營養組合物包含以下中之一者或其組合:(1)植物提取物及/或其衍生物,(2)一或多種礦物質,(3)一或多種地衣或真菌,(4)一或多種胺基酸或其衍生物。在尤其較佳實施例中,營養組合物包含至少一種植物提取物及/或其衍生物、至少一種礦物質、至少一種地衣或真菌及至少一種胺基酸或其衍生物。
植物提取物及/或其衍生物可為選自由以下組成之群的一者或組合:瑪卡根(maca root)提取物、蛇床子(cnidium monnieri seed)提取物、刺蒺黎豆(mucuna pruriens)、東革阿里(Tongkat ali)(Root LJ 100提取物)及長春西汀(vinpocetine)。在較佳實施例中,營養組合物包含前述植物提取物及/或衍生物中之至少兩者、較佳至少三者及最佳全部。
礦物質可選自鉀、氯、鈉、鈣、磷、鎂、鋅、鐵、錳、銅、碘、硒及鉬。在尤其較佳實施例中,組合物包含吡啶甲酸鋅。
至少一種地衣或真菌可為冬蟲夏草屬(cordyceps),諸如冬蟲夏草(cordyceps sinensis),及黃梅地衣(xanthoparmela scabrosa)提取物。
至少一種胺基酸可為一種或組合二甲基甘胺酸(DMG)、L-精胺酸α-酮戊二酸鹽、L-精胺酸及L-組胺酸。在一個較佳實施例中,營養組合物至少包含L-精胺酸。
在另一實施例中,營養組合物由以下組成:(1)一或多種植物提取物及/或其衍生物,(2)一或多種礦物質,(3)一或多種地衣或真菌,及(4)一或多種醫藥學上可接受之載劑。
在另一實施例中,營養組合物由以下組成:(1)一或多種植物提取物及/或其衍生物,(2)一或多種礦物質,(3)一或多種地衣或真菌,(4)一或多種胺基酸及/或其衍生物及(5)一或多種醫藥學上可接受之載劑。
一或多種醫藥學上可接受之載劑可包括黏合物質、賦形劑、染料、防腐劑、調味劑及抗細菌劑。非活性成份之特定實例包括椰子油、明膠、米糠油、甘油、水、葵花卵磷脂、黃蜂臘、二氧化鈦及著色劑。
在較佳實施例之一個態樣中,營養組合物包含以下之組合:(1)包含瑪卡根提取物、蛇床子提取物、刺蒺黎豆、東革阿里(Root LJ 100提取物)及長春西汀之植物提取物及/或其衍生物;(2)包含吡啶甲酸鋅之礦物質;及(3)至少一種地衣或真菌,包含蟲草(cordyceps)及黃梅地衣提取物。
在較佳實施例之第二態樣中,營養組合物包含以下之組合:(1)包含瑪卡根提取物、蛇床子提取物、刺蒺黎豆、東革阿里(Root LJ 100提取物)及長春西汀之植物提取物及/或其衍生物;(2)包含吡啶甲酸鋅之礦物質;(3)至少一種地衣或真菌,包含冬蟲夏草及黃梅地衣提取物;及(4)至少一種胺基酸,包含L-精胺酸。
在較佳實施例之第三態樣中,營養組合物由以下組成:(1)包含瑪卡根提取物、蛇床子提取物、刺蒺黎豆、東革阿里(Root LJ 100提取物)及長春西汀之植物提取物及/或其衍生物;(2)包含吡啶甲酸鋅之礦物質;(3)至少一種地衣或真菌,包含蟲草及黃梅地衣提取物;及(4)一或多種醫藥學上可接受之載劑。
在較佳實施例之第四態樣中,營養組合物由以下組成:(1)包含瑪卡根提取物、蛇床子提取物、刺蒺黎豆、東革阿里(Root LJ 100提取物)及長春西汀之植物提取物及/或其衍生物;(2)包含吡啶甲酸鋅之礦物質;(3)至少一種地衣或真菌,包含冬蟲夏草及黃梅地衣提取物;(4)至少一種胺基酸,包含L-精胺酸;及(5)一或多種醫藥學上可接受之載劑。
在較佳實施例之第五態樣中,營養組合物由以下組成:瑪卡根
提取物、蛇床子提取物、刺蒺黎豆、東革阿里(Root LJ 100提取物)、長春西汀、吡啶甲酸鋅、蟲草、黃梅地衣提取物及一或多種醫藥學上可接受之載劑。
在較佳實施例之第六態樣中,營養組合物由以下組成:瑪卡根提取物、蛇床子提取物、刺蒺黎豆、東革阿里(Root LJ 100提取物)、長春西汀、吡啶甲酸鋅、冬蟲夏草、黃梅地衣提取物、至少一種包含L-精胺酸之胺基酸及一或多種醫藥學上可接受之載劑。
在另一實施例中,提供一種用於治療或改善性功能障礙之方法。該方法包含向患者投與任一種本文中所述之營養組合物。
熟習此項技術者將自以下實施方式顯而易見所描述之較佳實施例之其他目標、特徵及優點。然而,應理解,當實施方式及特定實例指示本發明之較佳實施例時,該等實施方式及特定實例係以說明方式給出並非限制。在不偏離本發明之精神下,可進行本發明範疇內之許多改變及修改,且本發明包括所有該等修改。
現將參考較佳實施例描述本發明之特定、非限制性實施例。應理解,該等實施例係僅作為實例且僅為本發明範疇內少數實施例的說明。熟習本發明涉及之技術者顯而易見的各種變化及修改應視為屬於本發明之精神、範疇及意圖內,如隨附申請專利範圍中進一步定義。
在一個實施例中,組合物包含至少一種植物提取物或其衍生物。植物提取物可取自植物之葉、根、種子或任何其他組份。組合物可因此包含來自以下群之植物提取物或其衍生物之任一者或組合:瑪卡根提取物、蛇床子提取物、刺蒺黎豆、黃梅地衣、東革阿里及長春西汀。在一個尤其較佳實施例中,組合物包含下表1中所列之量之前
述植物提取物或其衍生物:
植物提取物或其衍生物中之任一者可藉由咸信有助於改善或增進男性性功能之活性成分替代。
瑪卡根為包含硫化葡萄糖苷、一種衍生自葡萄糖之有機化合物及胺基酸之秘魯植物。硫化葡萄糖苷以幾乎所有十字花(brassicales)目(包括十字花科、白花菜(capparidaceae)科及番瓜樹(caricaceae)科)以及核實(drypetes)屬之植物之二級代謝物的形式出現。咸信瑪卡根提取物包含約0.6%之硫化葡萄糖苷。因此,應理解瑪卡根提取物可藉由硫化葡萄糖苷或藉由另一種包含硫化葡萄糖苷之成份替代,諸如十字花目(包括十字花科、白花菜科及番瓜樹科)以及核實屬之植物。
蛇床子提取物含有蛇床子素,其為一種O-甲基化香豆素(O-methylated coumarin),且蛇床子提取物可包含約10-20%蛇床子素。蛇床子素為鈣離子通道阻斷劑且可存在於其他植物中,諸如歐白芷(angelica archangelica)及重齒毛當歸(angelica pubescens)。因此,應理解蛇床子可藉由蛇床子素或藉由包含蛇床子素之另一成份替代,諸如歐白芷及重齒毛當歸。
刺蒺黎豆含有左旋多巴,其為神經傳遞質多巴胺之前驅體,且
刺蒺黎豆可包含約15-50%左旋多巴。由此,刺蒺黎豆可藉由左旋多巴或包含左旋多巴之另一成份替代。
在另一實施例中,組合物進一步包含一或多種維生素、礦物質及其衍生物。維生素可包括維生素A、維生素B1、維生素B2、維生素B3、維生素B5、維生素B6、維生素B7、維生素B9、維生素B12、維生素C、維生素D、維生素E及維生素K。礦物質可包括鉀、氯、鈉、鈣、磷、鎂、鋅、鐵、錳、銅、碘、硒及鉬。在尤其較佳實施例中,組合物包含以列於下表2中之量存在之礦物質或其衍生物:
在另一實施例中,組合物進一步包含一或多種來自真菌、藻類或地衣之提取物。在尤其較佳實施例中,組合物進一步包含以列於下表3中之量存在之黃梅地衣,其為一種地衣:
冬蟲夏草屬為包括400個經鑑定之物種之子囊菌真菌的一個屬。咸信蟲草可提高男性體內固有性激素且由此提高慾力(libido)及性慾。在較佳實施例中,冬蟲夏草用於調配物中。咸信冬蟲夏草含有腺苷,較佳含有0.18%或更多的腺苷。
咸信黃梅地衣提取物包含哌嗪,其為咸信具有改善性功能之作用且可包含約35%哌嗪的有機化合物。因此,應理解,黃梅地衣提取物可藉由哌嗪或藉由包含哌嗪之另一成份替代。
在另一實施例中,組合物包含一或多種胺基酸或其衍生物。在尤其較佳實施例中,組合物包含以列於下表4中之量存在之胺基酸或其衍生物:
應理解,本文中所述之組合物可包含描述於表1至4中之組份之一者或組合,且該等組合物可進一步包含一或多種並不提高或影響此等組份之治療作用的藥學上可接受之載劑或非活性成份。非活性成份之實例包括黏合物質、賦形劑、染料、防腐劑、調味劑及抗細菌劑。非活性成分之特定實例包括椰子油、葵花卵磷脂、明膠、米糠油、甘油、水、黃蜂臘、二氧化鈦及著色劑。
在另一實施例中,提供用於治療或改善性功能障礙之方法。該方法包含向患者投與任一種本文中所述之營養組合物。
在一個實施例中,用於增進性健康之組合物經調配成硬膠囊或軟膠囊,其包含以列於以下之量存在之列於以下之成份:
在另一實施例中,用於增進性健康之組合物經調配成硬膠囊或軟膠囊,其包含以列於以下之數量存在之列於以下之成份:
本文中所描述及所主張之本發明之範疇不受本文中所揭示之特定較佳實施例限制,因為此等實施例意欲作為本發明之若干態樣的說明。實際上,熟習此項技術者將自前述說明顯而易見除本文中所展示及描述之修改以外的本發明之各種修改。該等修改亦意欲屬於隨附申請專利範圍之範疇內。
Claims (12)
- 一種醫藥組合物,其包含:一或多種植物提取物及/或其衍生物;一或多種維生素及/或礦物質;一或多種真菌、藻類及/或地衣;及一或多種醫藥學上可接受之載劑;其中該一或多種植物提取物、該一或多種維生素及/或礦物質及該一或多種真菌、藻類或地衣係以足以治療或改善患者之性功能障礙之量存在。
- 如請求項1之醫藥組合物,其中該一或多種植物提取物為選自由以下組成之群之一或多者:瑪卡根(maca root)提取物、蛇床子(cnidium monnieri seed)提取物、刺蒺黎豆(mucuna pruriens)、東革阿里(Tongkat ali)、長春西汀(vinpocetine)。
- 如請求項1之醫藥組合物,其中該一或多種維生素或礦物質為選自由以下組成之群之一或多者:維生素A、維生素B1、維生素B3、維生素B5、維生素B6、維生素B7、維生素B9、維生素B12、維生素C、維生素D、維生素E、維生素K、鉀、氯、鈉、鈣、磷、鎂、鋅、鐵、錳、銅、碘、硒及鉬。
- 如請求項1之醫藥組合物,其中該一或多種真菌、藻類或地衣係選自由以下組成之群:蟲草(cordyceps)、冬蟲夏草(cordyceps sinesis)及黃梅地衣(xanthoparmela scabrosa)提取物。
- 如請求項1之醫藥組合物,其進一步包含一或多種胺基酸及/或其衍生物。
- 如請求項5之醫藥組合物,其中該一或多種胺基酸及/或衍生物係選自由以下組成之群:二甲基甘胺酸、L-精胺酸及L-組胺酸。
- 如請求項1之醫藥組合物,其包含:刺蒺黎豆、冬蟲夏草、蛇床子提取物、黃梅地衣、瑪卡根提取物、東革阿里、吡啶甲酸鋅、L-精胺酸及長春西汀。
- 如請求項7之醫藥組合物,其包含:20-60mg刺蒺黎豆、100-300mg冬蟲夏草、40-120mg蛇床子提取物、20-60mg黃梅地衣、50-200mg瑪卡根提取物、50-200mg東革阿里、5-25mg吡啶甲酸鋅、20-80mg L-精胺酸及2-6mg長春西汀。
- 一種醫藥組合物,其由以下組成:刺蒺黎豆、冬蟲夏草、蛇床子提取物、黃梅地衣、瑪卡根提取物、東革阿里、吡啶甲酸鋅、長春西汀及一或多種醫藥學上可接受之載劑。
- 如請求項9之醫藥組合物,其由以下組成:100-200mg冬蟲夏草、100-200mg瑪卡根提取物、50-150mg蛇床子提取物、35-105mg刺蒺黎豆、20-60mg黃梅地衣、10-40mg東革阿里、2-12mg吡啶甲酸鋅、2-6mg長春西汀及一或多種醫藥學上可接受之載劑。
- 一種醫藥組合物,其由以下組成:刺蒺黎豆、冬蟲夏草、蛇床子提取物、黃梅地衣、瑪卡根提取物、東革阿里、吡啶甲酸鋅、L-精胺酸、長春西汀及一或多種醫藥學上可接受之載劑。
- 如請求項11之醫藥組合物,其由以下組成:20-60mg刺蒺黎豆、100-300mg冬蟲夏草、40-120mg蛇床子提取物、20-60mg黃梅地衣、50-200mg瑪卡根提取物、50-200mg東革阿里、5-25mg吡啶甲酸鋅、20-80mg L-精胺酸、2-6mg長春西汀及一或多種醫藥學上可接受之載劑。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361868922P | 2013-08-22 | 2013-08-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201511766A true TW201511766A (zh) | 2015-04-01 |
Family
ID=52484209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103129078A TW201511766A (zh) | 2013-08-22 | 2014-08-22 | 用於增進男性性健康之方法及組合物 |
Country Status (2)
Country | Link |
---|---|
TW (1) | TW201511766A (zh) |
WO (1) | WO2015027208A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105878765A (zh) * | 2016-05-18 | 2016-08-24 | 南京耕丰医药科技有限公司 | 一种中药组合物及其制备方法与应用 |
CN106974955A (zh) * | 2017-04-12 | 2017-07-25 | 云南省药物研究所 | 一种改善性功能障碍的玛咖提取物及其制备方法和应用 |
CN107760520A (zh) * | 2017-11-28 | 2018-03-06 | 姜德海 | 一种中药养生液及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2395447A1 (en) * | 2000-01-28 | 2001-08-02 | Robert Joseph Sarama | Palatable arginine compounds and uses thereof for cardiovascular health |
US20040067986A1 (en) * | 2002-10-04 | 2004-04-08 | Nathan Sassover | Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer |
US20090092687A1 (en) * | 2007-10-03 | 2009-04-09 | Stein Daniel S | Prhormone composition and method of use thereof |
US20090110674A1 (en) * | 2007-10-24 | 2009-04-30 | Loizou Nicos C | Health supplement |
CN101589802A (zh) * | 2008-05-28 | 2009-12-02 | 程礼华 | 一种精卵子保健酒 |
CN102612370B (zh) * | 2009-09-17 | 2014-10-29 | 特拉达药物有限公司 | 刺激男性性功能的膳食补充剂 |
-
2014
- 2014-08-22 WO PCT/US2014/052385 patent/WO2015027208A1/en active Application Filing
- 2014-08-22 TW TW103129078A patent/TW201511766A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015027208A1 (en) | 2015-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4292588A3 (en) | Administration of deuterated cftr potentiators | |
EA201992722A1 (ru) | N2,n4-дифенилпиримидин-2,4-диаминовое производное, способ его получения и фармацевтическая композиция, содержащая его в качестве активного ингредиента, для профилактики и лечения рака | |
MX2018014083A (es) | Composiciones nutritivas para la proteccion cardiaca en animales de compañia. | |
MX2017010544A (es) | Metodos y composiciones para tratar la enfermedad del ojo seco y otros trastornos del ojo. | |
MX344787B (es) | Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara. | |
PH12017502375A1 (en) | Method of treating inflammation using natural compounds and/or diet | |
MX2020010300A (es) | Sales monoacidas de 6-aminoisoquinolinas y usos de las mismas. | |
MX2022001565A (es) | Formas solidas de un estimulador de guanilato ciclasa soluble (sgc). | |
PH12016501357B1 (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
MX2022015629A (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
TW201511766A (zh) | 用於增進男性性健康之方法及組合物 | |
EA202091396A1 (ru) | Композиции и способы лечения метаболических состояний | |
MX2022011372A (es) | Composiciones de zinc-y-pga y metodos para tratar el cancer. | |
BR112015029897A2 (pt) | composição sólida para administração oral contendo ácido ibandrônico ou um seu sal farmaceuticamente aceitável e vitamina d e processo para obtenção da referida composição | |
PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
Uzun et al. | The effect of garlic derivatives (S-allylmercaptocysteine, diallyl disulfide, and S-allylcysteine) on gentamicin induced ototoxicity: An experimental study | |
GB2467084A (en) | Mitigation of animal and plant diseases using bioavailable minerals | |
PH12019502096A1 (en) | Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
BR112018067663A2 (pt) | compostos derivados de sulfamato, processos para preparação dos mesmos e seus usos | |
WO2015027201A1 (en) | Methods and compositions for enhancing female sexual wellness | |
MX2020001217A (es) | Metodos de tratamiento de sintomas de gastroparesia usando velusetrag. | |
Sekhar et al. | Chelating agents and antioxidants: pragmatic approaches for management of Buerger's disease | |
MX2015010765A (es) | Metodos y composiciones para tratar y prevenir una lesion intestinal y enfermedades relacionadas a la disfuncion de las uniones estrechas. | |
ZA202104167B (en) | Compounds for use in the treatment of parkinson's disease | |
UA114464U (xx) | Спосіб лікування атеросклерозу |